Gemini Therapeutics Stock Forecast - Triple Exponential Smoothing
| GMTXDelisted Stock | USD 17.95 0.05 0.28% |
The Triple Exponential Smoothing forecasted value of Gemini Therapeutics on the next trading day is expected to be 18.09 with a mean absolute deviation of 0.57 and the sum of the absolute errors of 33.54. Gemini Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Gemini Therapeutics stock prices and determine the direction of Gemini Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Gemini Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Gemini |
Most investors in Gemini Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Gemini Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Gemini Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Triple exponential smoothing for Gemini Therapeutics - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Gemini Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Gemini Therapeutics price movement. However, neither of these exponential smoothing models address any seasonality of Gemini Therapeutics. Gemini Therapeutics Triple Exponential Smoothing Price Forecast For the 26th of April
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Gemini Therapeutics on the next trading day is expected to be 18.09 with a mean absolute deviation of 0.57, mean absolute percentage error of 1.11, and the sum of the absolute errors of 33.54.Please note that although there have been many attempts to predict Gemini Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Gemini Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Gemini Therapeutics Stock Forecast Pattern
| Backtest Gemini Therapeutics | Gemini Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Gemini Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Gemini Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.1074 |
| MAD | Mean absolute deviation | 0.5684 |
| MAPE | Mean absolute percentage error | 0.0332 |
| SAE | Sum of the absolute errors | 33.5364 |
Predictive Modules for Gemini Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gemini Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gemini Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gemini Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gemini Therapeutics stock to make a market-neutral strategy. Peer analysis of Gemini Therapeutics could also be used in its relative valuation, which is a method of valuing Gemini Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Gemini Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Gemini Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gemini Therapeutics shares will generate the highest return on investment. By undertsting and applying Gemini Therapeutics stock market strength indicators, traders can identify Gemini Therapeutics entry and exit signals to maximize returns.
Gemini Therapeutics Risk Indicators
The analysis of Gemini Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Gemini Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gemini stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.27 | |||
| Semi Deviation | 4.1 | |||
| Standard Deviation | 7.06 | |||
| Variance | 49.88 | |||
| Downside Variance | 31.98 | |||
| Semi Variance | 16.81 | |||
| Expected Short fall | (4.18) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Gemini Stock
If you are still planning to invest in Gemini Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemini Therapeutics' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |